<DOC>
	<DOCNO>NCT02185924</DOCNO>
	<brief_summary>Combination continuous femoral block parEcoxib v placebo . Investigation morphine consumption , opioid sparing effect , VAS pain score , haemodynamics , Anxierty score , transfusion requirement , Range motion rehabilitation parameter two group</brief_summary>
	<brief_title>Combination Continuous Femoral Block Intravenous Parecoxib For Postoperative Analgesia After Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>PATIENTS ASA III UNDERGOING TOTAL KNEE ATRTHROPLASTY Exclusion criterion group include : Age young 40 year old old 80 year old ASA &gt; III Obesity ( &gt; 140 kg body weight ) Allergy local anesthetic History dependence opioids Contraindications subarachnoid anesthesia femoral block ( coagulopathy , local infection , preexist neurological problem , patient refusal ) Contraindications administration parecoxib Severe hepatic renal disease ( serum creatinine â‰¥ 1.7 mg/dl )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>PARECOXIB</keyword>
	<keyword>CONTINUOUS FEMORAL BLOCK</keyword>
</DOC>